125 results
DEFA14A
QNCX
Quince Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:05pm
of our issued and outstanding common stock at a ratio of one-for-ten. For 3. To ratify the selection of BDO USA, P.C. as the independent registered public
S-8
EX-23.2
QNCX
Quince Therapeutics Inc
1 Apr 24
Registration of securities for employees
5:21pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration
S-8
7vu7 3rpvs
1 Apr 24
Registration of securities for employees
5:21pm
8-K/A
6np7p chbko
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K/A
EX-23.1
92n4p57ao 00z8z1
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K/A
EX-99.2
ddl6u1guxk uc2dda6
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K/A
EX-99.1
pd5lj2j
5 Jan 24
Independent Auditors’ Report
4:01pm